Kazia Therapeutics (KZIA) Short Interest Ratio & Short Volume → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free KZIA Stock Alerts $0.27 -0.01 (-3.63%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Kazia Therapeutics Short Interest DataCurrent Short Interest48,200 sharesPrevious Short Interest86,000 sharesChange Vs. Previous Month-43.95%Dollar Volume Sold Short$13,009.18Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares16,340,000 sharesPercentage of Shares Shorted0.29%Today's Trading Volume186,654 sharesAverage Trading Volume165,423 sharesToday's Volume Vs. Average113% Short Selling Kazia Therapeutics ? Sign up to receive the latest short interest report for Kazia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKZIA Short Interest Over TimeKZIA Days to Cover Over TimeKZIA Percentage of Float Shorted Over Time Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. Kazia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202448,200 shares $13,009.18 -44.0%N/A0.1 $0.27 4/30/202486,000 shares $28,792.80 +367.4%N/A0.1 $0.33 4/15/202418,400 shares $5,648.80 -92.9%N/A0 $0.31 3/31/2024259,500 shares $80,393.10 +6.9%N/A0.3 $0.31 3/15/2024242,800 shares $54,362.92 -68.3%N/A0.3 $0.22 2/29/2024765,100 shares $195,177.01 +1,566.9%N/A1.1 $0.26 Get the Latest News and Ratings for KZIA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202445,900 shares $14,242.77 -74.7%N/A0.1 $0.31 1/31/2024181,700 shares $54,328.30 +54.5%N/A1 $0.30 1/15/2024117,600 shares $41,148.24 +103.1%N/A1.1 $0.35 12/31/202357,900 shares $25,447.05 +32.8%N/A0.6 $0.44 12/15/202343,600 shares $17,047.60 -40.3%N/A0.5 $0.39 11/30/202373,000 shares $40,931.10 -35.6%N/A0.9 $0.56 11/15/2023113,400 shares $87,658.20 +1,889.5%N/A1.6 $0.77 10/31/20235,700 shares $2,393.43 -95.0%N/A0.1 $0.42 10/15/2023113,800 shares $77,384.00 +116.8%N/A3.1 $0.68 9/30/202352,500 shares $52,250.63 +10.3%N/A1.3 $1.00 9/15/202347,600 shares $48,076.00 -24.3%N/A0.3 $1.01 8/31/202362,900 shares $57,245.29 +10.5%N/A0.3 $0.91 8/15/202356,900 shares $51,329.49 -33.5%N/A0.3 $0.90 7/31/202385,600 shares $86,456.00 -2.5%N/A0.5 $1.01 7/15/202387,800 shares $76,745.98 -36.8%N/A0.5 $0.87 6/30/2023139,000 shares $158,460.00 -3.6%N/A0.8 $1.14 6/15/2023144,200 shares $181,692.00 -10.7%N/A4.7 $1.26 5/31/2023161,500 shares $192,185.00 +20.3%N/A4.8 $1.19 5/15/2023134,300 shares $178,619.00 -24.4%N/A3 $1.33 4/30/2023177,700 shares $236,341.00 +28.2%N/A3.9 $1.33 4/15/2023138,600 shares $182,952.00 -2.0%N/A2.8 $1.32 3/31/2023141,400 shares $145,656.14 +10.0%N/A2.7 $1.03 3/15/2023128,600 shares $120,768.26 -8.5%N/A2.2 $0.94 2/28/2023140,600 shares $129,352.00 -3.8%N/A2.3 $0.92 2/15/2023146,100 shares $131,490.00 -17.3%N/A2.6 $0.90 1/31/2023176,700 shares $182,001.00 -28.5%N/A2.8 $1.03 1/15/2023247,100 shares $259,455.00 +64.2%N/A0.7 $1.05 12/30/2022150,500 shares $92,542.45 -7.8%N/A0.4 $0.61 12/15/2022163,300 shares $89,145.47 -6.1%N/A0.5 $0.55 11/30/2022173,900 shares $104,966.04 -3.4%N/A0.5 $0.60 11/15/2022180,100 shares $118,866.00 -75.8%N/A0.5 $0.66 10/31/2022744,000 shares $614,767.20 +526.3%N/A2.1 $0.83 10/15/2022118,800 shares $118,800.00 +7.1%N/A0.4 $1.00 9/30/2022110,900 shares $121,990.00 -5.9%N/A0.4 $1.10Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 9/15/2022117,900 shares $168,597.00 -20.7%N/A0.3 $1.43 8/31/2022148,700 shares $227,511.00 -24.8%N/A0.2 $1.53 8/15/2022197,700 shares $345,975.00 +68.7%N/A0.3 $1.75 7/31/2022117,200 shares $425,436.00 -19.0%N/A0.2 $3.63 7/15/2022144,600 shares $539,358.00 +113.9%N/A0.4 $3.73 6/30/202267,600 shares $283,920.00 +90.4%N/A0.2 $4.20 6/15/202235,500 shares $191,700.00 +86.8%N/A0.1 $5.40 5/31/202219,000 shares $110,010.00 -21.2%N/A0.7 $5.79 5/15/202224,100 shares $132,309.00 +225.7%N/A1.2 $5.49 4/30/20227,400 shares $47,582.00 -53.5%N/A0.5 $6.43 4/15/202215,900 shares $121,317.00 +45.9%N/A1.2 $7.63 3/31/202210,900 shares $84,039.00 +445.0%N/A0.7 $7.71 3/15/20222,000 shares $12,100.00 -79.4%N/A0.1 $6.05 2/28/20229,700 shares $65,184.00 +592.9%N/A0.5 $6.72 2/15/20221,400 shares $10,514.00 +55.6%N/A0.1 $7.51 1/31/2022900 shares $6,030.00 -64.0%N/A0 $6.70 1/15/20222,500 shares $19,500.00 -19.4%N/A0.1 $7.80 12/31/20213,100 shares $26,102.00 -59.2%N/A0.1 $8.42 12/15/20217,600 shares $55,860.00 +20.6%N/A0.3 $7.35 11/30/20216,300 shares $63,189.00 +162.5%N/A0.2 $10.03 11/15/20212,400 shares $26,856.00 +4.4%N/A0.1 $11.19 10/29/20212,300 shares $24,909.00 -37.8%N/A0.1 $10.83 10/15/20213,700 shares $38,850.00 -67.8%N/A0.1 $10.50 9/30/202111,500 shares $130,180.00 -27.7%N/A0.5 $11.32 9/15/202115,900 shares $165,042.00 -29.0%N/A0.6 $10.38 8/31/202122,400 shares $243,040.00 +21.7%N/A0.7 $10.85 8/13/202118,400 shares $174,800.00 -18.6%N/A0.6 $9.50 7/30/202122,600 shares $204,078.00 -3.0%N/A0.6 $9.03 7/15/202123,300 shares $223,214.00 -16.5%N/A0.6 $9.58 6/30/202127,900 shares $275,094.00 +57.6%N/A0.5 $9.86 6/15/202117,700 shares $189,921.00 -18.1%N/A0.2 $10.73 5/28/202121,600 shares $205,416.00 -14.3%N/A0.2 $9.51 5/14/202125,200 shares $239,904.00 -38.2%N/A0.2 $9.52 4/30/202140,800 shares $444,720.00 +1,175.0%N/A0.3 $10.90 4/15/20213,200 shares $36,544.00 -88.5%N/A0 $11.42 3/31/202127,700 shares $333,508.00 -27.1%N/A0.2 $12.04 3/15/202138,000 shares $417,240.00 +32.9%N/A0.3 $10.98 2/26/202128,600 shares $297,154.00 +236.5%N/A0.2 $10.39 2/12/20218,500 shares $85,850.00 -18.3%N/A0 $10.10 1/29/202110,400 shares $99,424.00 -35.0%N/A0 $9.56 1/15/202116,000 shares $164,640.00 No ChangeN/A0 $10.29 1/15/20205,400 shares $24,624.00 -73.3%N/A0.1 $4.56 12/31/201920,200 shares $89,700.12 -70.5%N/A0.3 $4.44 KZIA Short Interest - Frequently Asked Questions What is Kazia Therapeutics' current short interest? Short interest is the volume of Kazia Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 48,200 shares of KZIA short. Learn More on Kazia Therapeutics' current short interest. Is Kazia Therapeutics' short interest increasing or decreasing? Kazia Therapeutics saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 48,200 shares, a decline of 44.0% from the previous total of 86,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kazia Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kazia Therapeutics: Flora Growth Corp. (2.82%), Alaunos Therapeutics, Inc. (10.54%), GlycoMimetics, Inc. (3.63%), Galecto, Inc. (0.24%), Minerva Neurosciences, Inc. (0.50%), Tonix Pharmaceuticals Holding Corp. (0.82%), Orgenesis Inc. (0.72%), NeuroSense Therapeutics Ltd. (0.17%), Akari Therapeutics, Plc (0.16%), Kiora Pharmaceuticals, Inc. (0.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Kazia Therapeutics stock? Short selling KZIA is an investing strategy that aims to generate trading profit from Kazia Therapeutics as its price is falling. KZIA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kazia Therapeutics? A short squeeze for Kazia Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KZIA, which in turn drives the price of the stock up even further. How often is Kazia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZIA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: FLGC Short Squeeze TCRT Short Squeeze GLYC Short Squeeze GLTO Short Squeeze NERV Short Squeeze TNXP Short Squeeze ORGS Short Squeeze NRSN Short Squeeze AKTX Short Squeeze KPRX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZIA) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.